跳至主要内容
临床试验/JPRN-UMIN000048100
JPRN-UMIN000048100已完成未知

Durvalumab after chemoradiotherapy in non-small cell lung cancer harboring driver gene mutation/translocation: a retrospective multicenter study (HOT2101) - HOT2101

Hokkaido Lung Cancer Clinical Study Group(HOT)0 个研究点目标入组 88 人开始时间: 2022年6月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who were deemed inappropriate for enrollment by investigators

研究者

发起方
Hokkaido Lung Cancer Clinical Study Group(HOT)

相似试验

进行中(未招募)
1 期
Durvalumab (MEDI4736) After chemoRadioTherapy (DART) for NSCLC patients – a phase II translational and biomarker study investigating PDL1 positive and negative patients
EUCTR2019-002537-11-FIOslo University Hospital100
招募中
2 期
DART (19-14434) Durvalumab (MEDI4736) After chemoRadioTherapy (DART) for NSCLC patients – a phase II translational and biomarker study investigating PDL1 positive and negative patients
2022-502640-12-01Oslo University Hospital Hf130
进行中(未招募)
1 期
Durvalumab (MEDI4736) After chemoRadioTherapy (DART) for NSCLC patients – a phase II translational and biomarker study investigating PDL1 positive and negative patientson-small cell lung cancer (NLCLC)MedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2019-002537-11-LTOslo University Hospital100
已完成
2 期
Radiochemotherapy +/- Durvalumab for locally-advanced Anal Carcinoma. A multicenter, randomized, phase II trial of the German Anal Cancer Study GroupC21Malignant neoplasm of anus and anal canal
DRKS00020739Goethe Universität; Universitätsklinikum Frankfurt Goethe-Universität180
招募中
1 期
Radiochemotherapy +/- Durvalumab for locally-advanced Anal CarcinomaA multicenter, randomized, phase II trial of the German Anal Cancer Study Groupanal cancer (UICC-Stage IIB-IIIC, incl. T2>4cm Nany )MedDRA version: 21.1Level: PTClassification code 10002136Term: Anal cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10002137Term: Anal cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2018-003005-25-ATniversity Hospital Frankfurt, Goethe University178